CellGeneTech Inc. is a biopharmaceutical company established in Delaware, USA.

About Us

CellgeneTech Inc. is a US-based biotechnology company founded in 2024 with a mission to license high-potential targeted protein degradation (TPD) assets from the Asia-Pacific region and integrate US clinical development and business development expertise to develop BIC and FIC therapies to address unmet medical needs.

Home About Us
About Us
CellgeneTech Inc. is a US-based biotechnology company founded in 2024 with a mission to license high-potential targeted protein degradation (TPD) assets from the Asia-Pacific region and integrate US clinical development and business development expertise to develop BIC and FIC therapies to address unmet medical needs.

Our Management Team

CellgeneTech’s operational management integrates local expertise and strategic collaboration to drive success in the US market. Through an experienced leadership team, a focused project committee, and strong partnerships, CellgeneTech aims to maximize the value of its innovative pipeline.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
© 2025 CellGeneTech Inc. All Rights Reserved Cookie Policy